🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

RecruitingNAAges 7 Years - 17 YearsAllWashington University School of Medicine
NCT05582551 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with a diagnosis of pediatric cancer (diagnosis at \<18 years of age) * Treatment including chemotherapy and/or radiation therapy * Completion of all cancer therapy for at least 6 months and less than 2 years * Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine * Current age between 7 and 17 years of age (age where all of the screening tests are both valid and have been successfully performed by our group) * English speaking Exclusion Criteria: * Undergoing active cancer treatment * Patient under the care of the Late Effects Program at St. Louis Children's Hospital * Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening. * Parents and/or patient illiteracy * No contact with treatment team in the past two years * In foster care or without a legal guardian
💊

What it tests

  • Highlighting Patients at Risk for Sensory Screening (HPARSS)
📍

Where

1 site
St. Louis Children's Hospital - Washington University School of Medicine
St Louis, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy